NEPHROCARE HEALTH SERV L (NEPHROPLUS) 52 Week High Streak: Second Straight Session at Rs 770
- September 15, 2026
- Posted by: Harsh Piplani
- Category: News
NEPHROCARE HEALTH SERV L 52 Week High Streak: NEPHROCARE HEALTH SERV L (NEPHROPLUS) has now set a fresh 52-week high for its second straight session, with the stock rising 1.42% across the streak and touching Rs 770 as the latest peak. The latest figures confirm the repeated-high pattern, but they do not establish a company-specific catalyst for the continued move.
At 15 September 2026 at 9:22 AM IST, the stock last traded at Rs 757.95 versus a previous close of Rs 766.55, after opening at Rs 770 and moving between Rs 748.45 and Rs 770. Turnover stood at Rs 0.23 crore and market capitalisation at Rs 7,708.35 crore. For readers, the value lies less in one session’s high and more in the fact that NEPHROPLUS has now printed a fresh one-year high on consecutive sessions, which makes the streak itself the key signal to follow.
NEPHROCARE HEALTH SERV L 52 Week High Streak: Consecutive High Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 757.95 |
| Previous Close | Rs 766.55 |
| Today's Move | Rs -8.6 (-1.12%) |
| Open | Rs 770 |
| High | Rs 770 |
| Low | Rs 748.45 |
| Turnover | Rs 0.23 crore |
| Market Capitalisation | Rs 7,708.35 crore |
NEPHROCARE HEALTH SERV L (NEPHROPLUS) traded at Rs 757.95 versus the previous close of Rs 766.55, a fall of 1.12%. The stock opened at Rs 770, reached a high of Rs 770 and touched a low of Rs 748.45.
The NEPHROCARE HEALTH SERV L share price today showed a softer intraday position versus the previous close, even though the stock had already extended its 52-week-high run. It last traded at Rs 757.95, down Rs 8.60 or 1.12% from Rs 766.55. The day opened at Rs 770, matched the 52-week high at Rs 770, and then moved down to a low of Rs 748.45, placing the current price in the lower half of the day’s range.
That price path matters because the stock still sits inside a broader repeated-high pattern rather than a one-off spike. Turnover was Rs 0.23 crore, while market capitalisation stood at Rs 7,708.35 crore. In stock market coverage, NEPHROCARE HEALTH SERV L share price today needs to be read alongside the streak itself: the fresh one-year high was first triggered in the earlier session, and today’s trade shows how the stock is moving after that reference point. For investors scanning Stocks In News Today or 52 Week High Stocks, the distinction between the streak and a single-day breakout is important.
What the Repeated 52-Week Highs Show
NEPHROCARE HEALTH SERV L’s repeated 52-week highs show that the stock has continued to trade at new one-year peaks for a second straight session, with the cumulative streak move now at 1.42%. The latest high of Rs 770 is also the most recent reference point for the move, and the comparison with the earlier peak is straightforward: the stock has repeated the same one-year high pattern across consecutive sessions rather than merely testing it once.
What this means for readers is that the NEPHROCARE HEALTH SERV L 52 Week High Streak is an event-driven pattern, not a statement of why the move is happening. The numbers confirm the price behaviour, but they do not identify a company-specific trigger. That is why the more useful question is whether the streak continues to hold above the prior breakout level and whether subsequent trading preserves the pattern of higher reference points. In the language of stock performance, this is a repeated one-year high, not a lifetime record unless an explicit all-time high is provided.
NEPHROCARE HEALTH SERV L (NEPHROPLUS) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 7,708.35 crore |
| P/E Ratio | 100.32x |
| P/B Ratio | 6.8x |
| ROE | 9.22% |
| ROCE | 16.18% |
| EPS | Rs 7.64 |
| Book Value Per Share | Rs 112.78 |
| Dividend Yield | 0% |
NEPHROCARE HEALTH SERV L (NEPHROPLUS) fundamental metrics show P/E 100.32x, P/B 6.8x, ROE 9.22%, ROCE 16.18%. These figures provide context only and are not a buy or sell signal.
NEPHROCARE HEALTH SERV L has a market capitalisation of Rs 7708.35 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 100.32x, P/B at 6.8x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 9.22% and ROCE of 16.18%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 7.64, book value per share of Rs 112.78, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 46.95x, median ROE of 12.95%, median ROCE of 15.7%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Hospital & Healthcare Services |
| Benchmark Scope | same industry |
| Company P/E Ratio | 100.32x |
| Benchmark Median P/E | 46.95x |
| Benchmark Average P/E | 105.02x |
| Benchmark P/E Range | 7.18x to 1,570.12x |
| Company P/B Ratio | 6.8x |
| Benchmark Median P/B | 2.87x |
| Company ROE | 9.22% |
| Benchmark Median ROE | 12.95% |
| Company ROCE | 16.18% |
| Benchmark Median ROCE | 15.7% |
| Company Market Capitalisation | Rs 7,708.35 crore |
| Benchmark Median Market Cap | Rs 475.97 crore |
NEPHROCARE HEALTH SERV L (NEPHROPLUS) is classified under sector: Healthcare and industry: Hospital & Healthcare Services.
NEPHROCARE HEALTH SERV L (NEPHROPLUS) has a P/E ratio of 100.32x, which is above the benchmark median of 46.95x, a difference of +113.67%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
NEPHROCARE HEALTH SERV L (NEPHROPLUS) has a ROE of 9.22%, which is below the benchmark median of 12.95%, a difference of -28.8%. NEPHROCARE HEALTH SERV L (NEPHROPLUS) has a ROCE of 16.18%, which is above the benchmark median of 15.7%, a difference of +3.06%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Thyrocare Technologies Ltd. | THYROCARE | 8,727.03 | 49.5 | 13.87 | 29.05 | 38.3 |
| Kovai Medical Center & Hospital Ltd. | KOVAI | 6,788.36 | 26.48 | 4.89 | 20.33 | 22.89 |
| Jupiter Life Line Hospitals Ltd. | JLHL | 9,143.18 | 48.74 | 5.78 | 13.39 | 15.7 |
| Yatharth Hospital & Trauma Care Services Ltd. | YATHARTH | 9,311.69 | 51.4 | 5.1 | 10.06 | 13.3 |
| Healthcare Global Enterprises Ltd. | HCG | 10,353.36 | 454.49 | 7.68 | 2.04 | 9.77 |
NEPHROCARE HEALTH SERV L (NEPHROPLUS) has a P/E ratio of 100.32x compared with the displayed peer median of 49.5x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 9.22% compares with a peer median of 13.39% across the companies shown in the table. ROCE stood at 16.18% versus the displayed peer median of 15.7%, providing a capital-efficiency comparison. NEPHROCARE HEALTH SERV L (NEPHROPLUS) has a market capitalisation of Rs 7,708.35 crore. Among the 5 peers shown, 4 have a larger market capitalisation.
Why Investors Are Watching NEPHROCARE HEALTH SERV L
- The stock has set a fresh 52-week high for its second straight session.
- The cumulative streak move is 1.42% across the repeated highs.
- The latest one-year peak stands at Rs 770.
- The healthcare valuation backdrop is mixed, with NEPHROCARE HEALTH SERV L trading above the industry median P/E and P/B.
- Turnover, market cap and profit-return ratios place the stock on investors’ watchlists for stock performance tracking.
About NEPHROCARE HEALTH SERV L
NEPHROCARE HEALTH SERV L operates in the Hospital & Healthcare Services industry within the Healthcare sector. The company’s current market capitalisation is Rs 7,708.35 crore, and its latest trading profile includes a P/E ratio of 100.32, P/B ratio of 6.8, ROE of 9.22% and ROCE of 16.18%.
For readers comparing healthcare companies, the business sits in a segment where market capitalisation, valuation and operating returns can differ widely across listed peers. That makes NEPHROCARE HEALTH SERV L Stock News relevant not only because of the streak, but also because of how its valuation and returns compare with the broader industry set.
Track NEPHROCARE HEALTH SERV L on Univest
Track NEPHROCARE HEALTH SERV L on Univest for the latest Share Price Today, Stock News, Market Cap updates and company-specific coverage. The NEPHROCARE HEALTH SERV L 52 Week High Streak will remain relevant as long as the stock keeps printing new one-year highs across sessions.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
How many sessions has NEPHROCARE HEALTH SERV L been setting fresh 52-week highs?
Ans. NEPHROCARE HEALTH SERV L has set a fresh 52-week high for its second straight session. The repeated-high pattern is the key event, and the latest peak remains Rs 770.
What is the cumulative move across the NEPHROCARE HEALTH SERV L 52 Week High Streak?
Ans. The cumulative move across the streak is 1.42%. That figure captures the total change over the repeated-high run rather than just the latest intraday move.
What was the latest 52-week high for NEPHROPLUS?
Ans. The latest 52-week high was Rs 770. The stock touched that level again while extending its second straight session of fresh one-year highs. The stock moved -1.12% so far today.
Did the latest trading data confirm a company-specific catalyst?
Ans. No. The latest figures confirm the price pattern, but they do not establish a company-specific catalyst for the repeated highs. Investors should separate the price behaviour from the reason behind it.
How did NEPHROCARE HEALTH SERV L trade during the session?
Ans. The stock last traded at Rs 757.95 after opening at Rs 770 and moving between Rs 748.45 and Rs 770. It was down 1.12% versus the previous close of Rs 766.55.
Is NEPHROCARE HEALTH SERV L expensive compared with peers?
Ans. On the latest numbers, NEPHROCARE HEALTH SERV L trades at 100.32 times earnings, which is above the healthcare industry median of 46.95 and above several peers such as Kovai Medical Center & Hospital Ltd. and Artemis Medicare Services Ltd.
What does the company’s profitability profile show?
Ans. NEPHROCARE HEALTH SERV L reports ROE of 9.22% and ROCE of 16.18%. ROCE is slightly above the industry median, while ROE is below the sector median, so investors may compare both metrics together.
What should investors monitor next?
Ans. Investors can monitor whether the stock continues to print new one-year highs, how it trades relative to Rs 770, and whether valuation remains supported by operating performance and sector context. The streak itself is the immediate focus.
Track NEPHROCARE HEALTH SERV L (NEPHROPLUS) Share Price on Univest
Use NEPHROCARE HEALTH SERV L (NEPHROPLUS) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
